Fever and Rash: A Changing Landscape in the 21st Century
Tài liệu tham khảo
2008, Measles—United States, January 1-April 25, 2008, MMWR Morb Mortal Wkly Rep, 57, 494
Ehresmann, 2004, An outbreak of measles among unvaccinated young adults and measles seroprevalence study: implications for measles outbreak control in adult populations, J Infect Dis, 189, S104, 10.1086/377714
Parker, 2006, Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States, N Engl J Med, 355, 447, 10.1056/NEJMoa060775
Pickering, 2006, Measles
Stevens, 1999, The flesh-eating bacterium: what's next?, J Infect Dis, 179, S366, 10.1086/513851
Aguero, 2008, Outbreak of invasive group A streptococcal disease among children attending a day-care center, Pediatr Infect Dis J, 27, 602, 10.1097/INF.0b013e31816a0e0a
Cockerill, 1997, An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children, JAMA, 277, 38, 10.1001/jama.1997.03540250046030
Efstratiou, 2000, Group A streptococci in the 1990s, J Antimicrob Chemother, 45, 3, 10.1093/jac/45.suppl_1.3
Steer, 2007, Group A streptococcal infections in children, J Paediatr Child Health, 43, 203, 10.1111/j.1440-1754.2007.01051.x
Carapetis, 2005, The global burden of group A streptococcal diseases, Lancet Infect Dis, 5, 685, 10.1016/S1473-3099(05)70267-X
Luca-Harari, 2008, Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004, J Clin Microbiol, 46, 79, 10.1128/JCM.01626-07
O'Loughlin, 2007, The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004, Clin Infect Dis, 45, 853, 10.1086/521264
Darenberg, 2007, Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden, Clin Infect Dis, 45, 450, 10.1086/519936
Pickering, 2006, MRSA
Riley, 1995, Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia, Med J Aust, 163, 412, 10.5694/j.1326-5377.1995.tb124656.x
Benjamin, 2007, Practical management: community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): the latest sports epidemic, Clin J Sport Med, 17, 393, 10.1097/JSM.0b013e31814be92b
Safdar, 2008, The risk of infection after nasal colonization with Staphylococcus aureus, Am J Med, 121, 310, 10.1016/j.amjmed.2007.07.034
Moran, 2006, Methicillin-resistant S. aureus infections among patients in the emergency department, N Engl J Med, 355, 666, 10.1056/NEJMoa055356
Stryjewski, 2008, Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus, Clin Infect Dis, 46, S368, 10.1086/533593
Lee, 2004, Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus, Pediatr Infect Dis J, 23, 123, 10.1097/01.inf.0000109288.06912.21
Levine, 2008, Vancomycin: understanding its past and preserving its future, South Med J, 101, 284, 10.1097/SMJ.0b013e3181647037
Pickering, 2006, Meningococcus
Andersen, 1997, Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group, J Infect, 34, 227, 10.1016/S0163-4453(97)94255-9
Jodar, 2002, Development of vaccines against meningococcal disease, Lancet, 359, 1499, 10.1016/S0140-6736(02)08416-7
Stephens, 2007, Epidemic meningitis, meningococcaemia, and Neisseria meningitidis, Lancet, 369, 2196, 10.1016/S0140-6736(07)61016-2
Inglesby, 2002, Anthrax as a biological weapon, 2002: updated recommendations for management, JAMA, 287, 2236, 10.1001/jama.287.17.2236
Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am 2008; 26:517-47, x-xi.
Pickering, 2006, Anthrax
Pickering, 2006, Smallpox
O'Brien, 2003, Recognition and management of bioterrorism infections, Am Fam Physician, 67, 1927
Richard, 2008, Bioterrorism: class A agents and their potential presentations in immunocompromised patients, Clin J Oncol Nurs, 12, 295, 10.1188/08.CJON.295-302